5-(2-AMINO-ETHYL)-2-HYDROXY-BENZOIC ACID HYDROBROMIDE, 97.0%, 1g

4,6-O-BENZYLIDENE-D-GLUCAL, 95.0%, 250mg

3-Methyl-5-isoxazoleacetic acid, 97.0%, 1g

6-Hydroxy-1,3-dimethylquinazoline-2,4(1H,3H)-dione, 98%, 1g

(2-(4-(Methoxycarbonyl)piperidin-1-yl)pyrimidin-5-yl)boronic acid, 95.0%, 5g

Methyl 3-Aminopyridine-2-carboxylate, 97.0%, 100g

5-(2-Chloropyridin-4-yl)-3-(3-(trifluoromethyl)phenyl)-1,2,4-oxadiazole, 97%, 1g

DL-Norvaline, 99.0%, 25g

(1-Benzyl-piperidin-4-yl)-N-methyl-amine, 97.0%, 1g

2-Hydroxy-4-methylpyridine>98.0%(GC)(T)5g

(1-(1-ETHOXY-2-METHYL-1-OXOPROPAN-2-YL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 100mg

3-Methoxy-5-methylpyridine, 95+%, 500mg

GC capillary column ROTI®Cap-1, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)